Ab&B Biotech Co.,Ltd. is committed to the full-cycle development of innovative human vaccines from research and development through registration, industrial production to commercialization while adhering to international standards and maintaining our focus on independent innovation. Our Shanghai and Taizhou R&D Centers with pilot-scale platforms are actively developing multiple vaccine pipelines including viral vaccines, bacterial vaccines, conjugate vaccines, recombinant subunit vaccines and mRNA vaccines.